On May 8, 2024, JHM Biopharmaceutical (Hangzhou) Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10 CNY | +0.10% | -0.60% | -7.66% |
May. 15 | Tonghua Dongbao Pharmaceutical Launches Phase 1 Trial for Diabetes Injection in China | MT |
May. 10 | Dongbao Pharmaceutical's Deputy General Manager to Reduce Stake | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.66% | 2.72B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.56% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.47% | 8.82B |
- Stock Market
- Equities
- 600867 Stock
- News Tonghua Dongbao Pharmaceutical Co., Ltd.
- JHM Biopharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from Tonghua Dongbao Pharmaceutical Co., Ltd.